Longbow and Unilever ventures back CyDen light-based therapy
Longbow Capital has led a £2.8m third round of funding in CyDen, a Swansea-based medical devices company which is developing intense pulsed light (IPL) technology.
Unilever
Longbow Capital has led a £2.8m third round of funding in CyDen, a Swansea-based medical devices company which is developing intense pulsed light (IPL) technology.
Unilever